Literature DB >> 8861091

Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls.

B Saletu1, N Brandstätter, M Metka, M Stamenkovic, P Anderer, H V Semlitsch, G Heytmanek, J Huber, J Grünberger, L Linzmayer, C Kurz, K Decker, G Binder, W Knogler, B Koll.   

Abstract

UNLABELLED: The aim of the study was to investigate brain function in menopausal depression by EEG mapping, as compared with menopausal syndrome patients without depression and normal controls, and to correlate neurophysiological with clinical and hormonal findings in order to elucidate the pathogenesis of depression in the menopause.
METHODS: One hundred and twenty-nine menopausal women, aged 45-60 years, with no previous hormonal replacement therapy were investigated in regard to hormones (estradiol [E2], follicle stimulating hormone [FSH]), clinical symptomatology (Kupperman Index [KI], Hamilton depression score [HAMD]) and brain function (EEG mapping). Based on KI and DSM-III-R research criteria for major depression, 3 groups were available for statistics (after removal of protocol violators): group A had a KI of <15 and no depression (n = 29); group B had a KI of > or = 15 and no depression (n = 29) and group C had a KI of > or = 15 and fulfilled the criteria for major depression (n = 60).
RESULTS: EEG maps of depressed patients demonstrated less total power and absolute power in the delta, theta and beta band, more relative delta and less alpha power as well as a slower delta/theta and faster alpha and beta centroid than controls, suggesting a vigilance decrement. Group B did not differ from group A. Correlation maps showed significant relationships between estradiol levels and EEG measures (the lower the E2, the worse the vigilance) and between the EEG measures and the Hamilton depression (HAMD) score (the worse the vigilance, the higher the depression score). There were no correlations between the hormones E2 and FSH and the syndromes KI and HAMD. In the target variable, the asymmetry index, depressed patients showed less alpha power over the right than left frontal lobe, whereas normal controls exhibited the opposite. Group B did not differ from group A. The frontal asymmetry index was significantly correlated with the Hamilton depression score and suggests right frontal hyper- and left frontal hypoactivation in depression.
CONCLUSIONS: Although hormonal findings are not directly linked to psychic changes, low estradiol levels do contribute to a decreased vigilance at the neurophysiological level , which is in turn correlated with higher depressive and menopausal symptomatology at the behavioural level. Depression is further correlated to a right frontal hyper- and left frontal hypoactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861091     DOI: 10.1016/0378-5122(95)00946-9

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  14 in total

1.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.

Authors:  M Saletu; P Anderer; G M Saletu-Zyhlarz; M Mandl; O Arnold; J Zeitlhofer; B Saletu
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

3.  17β-estradiol differentially regulates stress circuitry activity in healthy and depressed women.

Authors:  Emily G Jacobs; Laura M Holsen; Katie Lancaster; Nikos Makris; Sue Whitfield-Gabrieli; Anne Remington; Blair Weiss; Stephen Buka; Anne Klibanski; Jill M Goldstein
Journal:  Neuropsychopharmacology       Date:  2014-08-12       Impact factor: 7.853

Review 4.  New progestogens: a review of their effects in perimenopausal and postmenopausal women.

Authors:  Régine Sitruk-Ware
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 5.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 6.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

7.  Postmenopausal estrogen therapy and depressive symptoms in older women.

Authors:  M A Whooley; D Grady; J A Cauley
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

8.  Near-Infrared Spectroscopy Reveals Abnormal Hemodynamics in the Left Dorsolateral Prefrontal Cortex of Menopausal Depression Patients.

Authors:  Xiang-Yun Ma; Yong-Jun Wang; Bo Xu; Kun Feng; Gao-Xiang Sun; Xiao-Qian Zhang; Xiao-Min Liu; Chen-Yu Shen; Xia-Jin Ren; Jing-Jing Sun; Po-Zi Liu
Journal:  Dis Markers       Date:  2017-02-14       Impact factor: 3.434

9.  The biopsychosocial effects of restless legs syndrome (RLS).

Authors:  Philip M Becker
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

Review 10.  Frontal alpha asymmetry as a diagnostic marker in depression: Fact or fiction? A meta-analysis.

Authors:  Nikita van der Vinne; Madelon A Vollebregt; Michel J A M van Putten; Martijn Arns
Journal:  Neuroimage Clin       Date:  2017-07-15       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.